Brief: Cure Pharmaceutical To Acquire Sera Labs
28/07/2020 13:08
July 28 (Reuters) - Cure Pharmaceutical Holding Corp
CURR.PK :
* CURE PHARMACEUTICAL TO ACQUIRE SERA LABS, A LEADER IN THE
CBD
INDUSTRY WITH PROPRIETARY PRODUCTS AND MULTI-CHANNEL
DISTRIBUTION PLATFORM, IN A $20 MILLION TRANSACTION
* CURE PHARMACEUTICAL HOLDING CORP - MOU TO ACQUIRE 100% OF
PRIVATELY HELD SERA LABS FOR $20 MILLION
* CURE PHARMACEUTICAL - KEY EARN OUT CONSIDERATIONS TOTALING
UP TO
ADDITIONAL $20 MILLION WITHIN TWO YEARS OF COMPLETING DEAL
Source text for Eikon: ID:nGNXbchBwJ
Further company coverage: CURR.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Avenir Wellness Solutions
See all newsBrief: Cure Pharmaceutical Reports Q2 2022 Results
Brief: Cure Pharmaceutical Announces Rob Davidson As New Chairman Of The Board And Appointment Of Rob Costantino As Member Of The Board And Audit Committee Chairman
Brief: Cure Pharmaceutical Holding Q1 Revenue $1.5 Million
Brief: CURE Pharmaceutical Augments Its Existing U.S. DEA License
Brief: Cure Pharmaceutical Receives FDA Approval For Its IND Application For Curefilm Blue